Literature DB >> 21232687

Correlation of findings in advanced MRI techniques with global severity scales in patients with Parkinson disease.

Pedro J Modrego1, Nicolás Fayed, Jorge Artal, Salvador Olmos.   

Abstract

RATIONALE AND
OBJECTIVES: This work is aimed at determining whether magnetic resonance spectroscopy (MRS) and diffusion tensor imaging (DTI) may correlate with disease severity in a series of Parkinson disease (PD) patients.
MATERIALS AND METHODS: We recruited a consecutive sample of 39 PD patients in several stages of the disease according to Hoehn and Yahr scale. There were 22 men, and the mean age was 74.5 years (SD 7.5). Disease severity was measured with the Unified Parkinson Disease Rating Scale (UPDRS). All of them underwent ¹H MRS in basal ganglia and the anterior cingulate area, as well as DTI in bilateral substantia nigra. Correlation was made between radiological findings and UPDRS.
RESULTS: We found significant negative correlation between UPDRS scores and the Glx (glutamate+glutamine) levels in the right (r = -0.35; P = .03) and the left (r = -0.44; P = .006) lentiform nucleus; as well as with glutamate (r = -0.43; P = .008), the Glx/Cr ratio in the right (r = -0.41; P = .01), and in the left lentiform nucleus (r = -0.36; P = .02). We also found positive correlation between UPDRS scores and DTI in right rostral substantia nigra (r = 0.36; P = .02). Glx was increased in lentiform nucleus and fractional anisotropy was reduced in the rostral SN of subjects with PD in early stages.
CONCLUSIONS: The results are consistent with the view that more than half the dopaminergic neurons in the nigrostriatal projection are lost before the onset of PD. Copyright Â
© 2011 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21232687     DOI: 10.1016/j.acra.2010.09.022

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  16 in total

Review 1.  Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

Authors:  Gerard Sanacora; Giulia Treccani; Maurizio Popoli
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

2.  Correlations between plasma levels of amino acids and nonmotor symptoms in Parkinson's disease.

Authors:  Qing Tong; Qinrong Xu; Qiang Xia; Yongsheng Yuan; Li Zhang; Hongbin Sun; Han Shan; Kezhong Zhang
Journal:  J Neural Transm (Vienna)       Date:  2014-07-25       Impact factor: 3.575

3.  Alterations of diffusion tensor MRI parameters in the brains of patients with Parkinson's disease compared with normal brains: possible diagnostic use.

Authors:  Chin-Song Lu; Shu-Hang Ng; Yi-Hsin Weng; Jur-Shan Cheng; Wey-Yil Lin; Yau-Yau Wai; Yao-Liang Chen; Jiun-Jie Wang
Journal:  Eur Radiol       Date:  2016-03-05       Impact factor: 5.315

4.  Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study.

Authors:  Thais Minett; Li Su; Elijah Mak; Guy Williams; Michael Firbank; Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Adrian M Owen; Tien K Khoo; David J Brooks; James B Rowe; Roger A Barker; David Burn; John T O'Brien
Journal:  J Neurol       Date:  2018-04-25       Impact factor: 4.849

5.  Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias.

Authors:  Nur-Ezan Mohamed; David R Howlett; Lu Ma; Paul T Francis; Dag Aarsland; Clive G Ballard; Ian G McKeith; Christopher P Chen; Mitchell K P Lai
Journal:  J Neural Transm (Vienna)       Date:  2013-07-12       Impact factor: 3.575

6.  Diffusion tensor imaging and correlations to Parkinson rating scales.

Authors:  Niklas Lenfeldt; William Hansson; Anne Larsson; Lars Nyberg; Richard Birgander; Lars Forsgren
Journal:  J Neurol       Date:  2013-08-23       Impact factor: 4.849

7.  Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study.

Authors:  Stefano Delli Pizzi; Cosmo Rossi; Vincenzo Di Matteo; Ennio Esposito; Simone Guarnieri; Maria Addolorata Mariggiò; Raffaella Franciotti; Massimo Caulo; Astrid Thomas; Marco Onofrj; Armando Tartaro; Laura Bonanni
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

Review 8.  Magnetic Resonance Techniques Applied to the Diagnosis and Treatment of Parkinson's Disease.

Authors:  Benito de Celis Alonso; Silvia S Hidalgo-Tobón; Manuel Menéndez-González; José Salas-Pacheco; Oscar Arias-Carrión
Journal:  Front Neurol       Date:  2015-07-03       Impact factor: 4.003

9.  White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function.

Authors:  Charlotte L Rae; Marta M Correia; Ellemarije Altena; Laura E Hughes; Roger A Barker; James B Rowe
Journal:  Neuroimage       Date:  2012-06-17       Impact factor: 6.556

10.  White-matter changes correlate with cognitive functioning in Parkinson's disease.

Authors:  Rebecca J Theilmann; Jason D Reed; David D Song; Mingxiong X Huang; Roland R Lee; Irene Litvan; Deborah L Harrington
Journal:  Front Neurol       Date:  2013-04-12       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.